Is Shanghai Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Shanghai Pharmaceuticals pays dividends. Last time was Friday 25th of October 2024 where the investors holding the stock on Tuesday 17th of September 2024 were paid HKD0.087355 per share. Over the last 15 times between 2012 and 2024, Shanghai Pharmaceuticals has paid HKD6.093975 with an average of HKD0.41 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Shanghai Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD14.72, you would have made a loss of HKD-4.20 per share or -28.53%
Yes, the average daily trading liquidity for Shanghai Pharmaceuticals is HKD2.95 million. You should therefore be able to get in and out of your positions relatively fast.
Shanghai Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a low cash flow to debt ratio of 0.05, the company's ability to pay off the debt is limited. The company has a very low net profit margin of 1.44%, which is challenging.
We have calculated the inflation risk for Shanghai Pharmaceuticals to be medium [0.65 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.